Drug intelligence / Profile preview

C12-iE-DAP

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

C12-iE-DAP is a synthetic, cell-permeable acylated derivative of the peptidoglycan dipeptide iE-DAP (gamma-D-Glu-mDAP). It acts as a potent and specific agonist for the Nucleotide-binding Oligomerization Domain-containing protein 1 (NOD1), an intracellular pattern recognition receptor. By mimicking bacterial motifs, C12-iE-DAP triggers the NOD1 signaling pathway, leading to the activation of NF-κB and MAPK pathways, and the production of inflammatory cytokines. In the context of immune thrombocytopenia (ITP) during pregnancy, it has been investigated for its ability to ameliorate bone marrow mesenchymal stem cell (BM-MSC) injury and promote platelet production via the IFN-I/STAT1 signaling cascade. The molecule incorporates a lauroyl (C12) fatty acid chain to enhance membrane permeability compared to the parent dipeptide.

Other names
lauroyl-gamma-D-glutamyl-meso-diaminopimelic acidlauroyl-iE-DAPNOD1 agonistNOD-1 agonistNOD 1 agonistNOD1 ligandNOD-1 ligandNOD 1 ligand
02

Targets

NOD1 (Nucleotide-binding oligomerization domain-containing protein 1)

Beyond the preview

Go deeper on C12-iE-DAP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C12-iE-DAP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call